Roche's Major US Investment

F. Hoffmann-La Roche AG has announced a groundbreaking $50 billion investment in the United States, set to unfold over the next five years. This ambitious plan aims to bolster the company's manufacturing capabilities and establish new facilities across key states including Indiana, Pennsylvania, Massachusetts, and California.

Expanding Workforce and Commitment

As part of this expansive initiative, Roche is expected to create over 12,000 new jobs, significantly increasing its workforce in the US. "Roche is a Swiss company with a strong heritage in more than 130 countries globally. Today's announced investments underscore our long-standing commitment to research, development, and manufacturing in the US," stated Roche Group CEO Thomas Schinecker.

Strengthening Global Presence

This strategic move not only reinforces Roche's dedication to innovation and healthcare excellence but also solidifies its position as a global leader in the pharmaceutical industry. The investment is a testament to the company's confidence in the US market and its potential for growth and innovation.